3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Withdrawn
1
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Carcinoma, Non-Small-Cell Lung
16
Breast Neoplasms
14
Prostatic Neoplasms
11
Neoplasm Metastasis
7
Lung Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
3
Sarcoma
3
Salivary Gland Neoplasms
3
Histiocytoma, Malignant Fibrous
3
Head and Neck Neoplasms
3
Dermatofibrosarcoma
3
Bone Neoplasms
3
Urinary Bladder Neoplasms
2
Solid Tumors
2
Small Cell Lung Carcinoma
2
Sarcoma, Synovial
2
Rhabdomyosarcoma
2
Neoplasms
2
Liposarcoma
2
Leiomyosarcoma
2
Hemangiosarcoma
2
Esthesioneuroblastoma, Olfactory
2
Carcinoma, Transitional Cell
2
Uterine Cervical Neoplasms
1
Thyroid Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Thyroid Cancer, Papillary
1
Recurrent Squamous Cell Lung Carcinoma
1
Pathologic Complete Response
1
Ovarian Neoplasms
1
Interventions
niraparib
1
Prednisone
1
Docetaxel
1
Androgen Antagonists
1
Abiraterone Acetate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
×
Docetaxel
×
Clear all
NCT06392841
2026-04-08
HARMONY
Hoosier Cancer Research Network
Phase 2
Withdrawn